Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Celsion Corporation is a biotechnology business based in the US. Celsion Corporation shares (CLSN) are listed on the NASDAQ and all prices are listed in US Dollars. Celsion Corporation employs 27 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$1.00|
|52-week range||$0.43 - $3.48|
|50-day moving average||$1.00|
|200-day moving average||$1.12|
|Wall St. target price||$3.25|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.40|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-12)||2.39%|
|1 month (2021-09-17)||-5.94%|
|3 months (2021-07-19)||-10.98%|
|6 months (2021-04-19)||-9.36%|
|1 year (2020-10-16)||59.72%|
|2 years (2019-10-18)||-42.20%|
|3 years (2018-10-18)||2.64|
|5 years (2016-10-18)||1.09|
|Gross profit TTM||$-10,844,819|
|Return on assets TTM||-18.7%|
|Return on equity TTM||-50.35%|
|Market capitalisation||$86.6 million|
TTM: trailing 12 months
There are currently 1.6 million Celsion Corporation shares held short by investors – that's known as Celsion Corporation's "short interest". This figure is 4.3% down from 1.7 million last month.
There are a few different ways that this level of interest in shorting Celsion Corporation shares can be evaluated.
Celsion Corporation's "short interest ratio" (SIR) is the quantity of Celsion Corporation shares currently shorted divided by the average quantity of Celsion Corporation shares traded daily (recently around 1.1 million). Celsion Corporation's SIR currently stands at 1.45. In other words for every 100,000 Celsion Corporation shares traded daily on the market, roughly 1450 shares are currently held short.
However Celsion Corporation's short interest can also be evaluated against the total number of Celsion Corporation shares, or, against the total number of tradable Celsion Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Celsion Corporation's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Celsion Corporation shares in existence, roughly 20 shares are currently held short) or 0.0191% of the tradable shares (for every 100,000 tradable Celsion Corporation shares, roughly 19 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Celsion Corporation.
Find out more about how you can short Celsion Corporation stock.
We're not expecting Celsion Corporation to pay a dividend over the next 12 months.
Celsion Corporation's shares were split on a 1:14 basis on 29 May 2017. So if you had owned 14 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Celsion Corporation shares – just the quantity. However, indirectly, the new 1300% higher share price could have impacted the market appetite for Celsion Corporation shares which in turn could have impacted Celsion Corporation's share price.
Over the last 12 months, Celsion Corporation's shares have ranged in value from as little as $0.4305 up to $3.48. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Celsion Corporation's is 1.9667. This would suggest that Celsion Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and vaccines. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for the treatment of primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product, which is in Phase II clinical trials for the localized treatment of ovarian cancers. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey. .
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.